Country Profile

Switzerland

Switzerland is a growing market for Indian pharmaceuticals — $70.0M in FY 2025–26. Medicine Ingredients accounts for 74% of shipments, with vaccines contributing $104K.

🇨🇭 $70.0M · 1.2× growth since FY2015 · 1.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$70.0M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
1.5%
CAGR FY2015→2026
74%
Medicine Ingredients Share
5
Product Categories Supplied
Switzerland is a growing market for Indian pharmaceuticals — $70.0M in FY 2025–26. Medicine Ingredients accounts for 74% of shipments, with vaccines contributing $104K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $51.8M (74.1%) Medicines $13.1M (18.8%) Surgical & Hospital Supplies $4.35M (6.2%) Traditional & Herbal $556K (0.8%) Vaccines $104K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Switzerland in the RBI overseas direct investment dataset (2011–2026).